Centene's recent stock drop is closely linked to a combination of higher-than-expected medical costs amid challenging trends in the Affordable Care Act (ACA) market and anticipation of the scheduled end to enhanced ACA subsidies at the end of 2025. While shares jumped earlier this week after Centene affirmed its guidance, which was higher than analysts' estimates, it faces an uncertain road ahead.
Yvette Digan, a Boston University exchange student from Hong Kong, describes her extreme pain as "like needles stabbing you," following severe burns from a fraternity incident.